193 related articles for article (PubMed ID: 27081479)
1. Strategically targeting MYC in cancer.
Posternak V; Cole MD
F1000Res; 2016; 5():. PubMed ID: 27081479
[TBL] [Abstract][Full Text] [Related]
2. Targeting MYC Dependence by Metabolic Inhibitors in Cancer.
Sabnis HS; Somasagara RR; Bunting KD
Genes (Basel); 2017 Mar; 8(4):. PubMed ID: 28362357
[No Abstract] [Full Text] [Related]
3. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Approaches Targeting MYC-Driven Prostate Cancer.
Rebello RJ; Pearson RB; Hannan RD; Furic L
Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28212321
[TBL] [Abstract][Full Text] [Related]
5. Strategies to target the cancer driver MYC in tumor cells.
Weber LI; Hartl M
Front Oncol; 2023; 13():1142111. PubMed ID: 36969025
[TBL] [Abstract][Full Text] [Related]
6. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms.
Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS
Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731
[TBL] [Abstract][Full Text] [Related]
7. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
Jeong KC; Ahn KO; Yang CH
Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
10. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.
Chen D; Zhao Z; Huang Z; Chen DC; Zhu XX; Wang YZ; Yan YW; Tang S; Madhavan S; Ni W; Huang ZP; Li W; Ji W; Shen H; Lin S; Jiang YZ
Bone Res; 2018; 6():11. PubMed ID: 29644114
[TBL] [Abstract][Full Text] [Related]
11. Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling.
Zaytseva O; Quinn LM
Genes (Basel); 2017 Apr; 8(4):. PubMed ID: 28398229
[TBL] [Abstract][Full Text] [Related]
12. Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription.
Pomplun S; Jbara M; Schissel CK; Wilson Hawken S; Boija A; Li C; Klein I; Pentelute BL
ACS Cent Sci; 2021 Aug; 7(8):1408-1418. PubMed ID: 34471684
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1.
Satterwhite DJ; White RL; Aakre ME; Moses HL
Pediatr Res; 2001 Jul; 50(1):67-75. PubMed ID: 11420421
[TBL] [Abstract][Full Text] [Related]
14. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Myc.
Prochownik EV; Vogt PK
Genes Cancer; 2010 Jun; 1(6):650-659. PubMed ID: 21132100
[TBL] [Abstract][Full Text] [Related]
16. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
[TBL] [Abstract][Full Text] [Related]
17. DKC1 is a direct and conserved transcriptional target of c-MYC.
Alawi F; Lee MN
Biochem Biophys Res Commun; 2007 Nov; 362(4):893-8. PubMed ID: 17822678
[TBL] [Abstract][Full Text] [Related]
18. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.
Ambrosini G; Sawle AD; Musi E; Schwartz GK
Oncotarget; 2015 Oct; 6(32):33397-409. PubMed ID: 26397223
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
20. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
